These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18215608)

  • 1. Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease.
    Stefanescu A; Braun S; Ndrepepa G; Koppara T; Pavaci H; Mehilli J; Schömig A; Kastrati A
    Am Heart J; 2008 Feb; 155(2):356-60. PubMed ID: 18215608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.
    Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Schömig A; Kastrati A
    Eur J Clin Invest; 2008 Feb; 38(2):90-6. PubMed ID: 18226042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease.
    Ndrepepa G; Kastrati A; Braun S; Koch W; Kölling K; Mehilli J; Schömig A
    Clin Chim Acta; 2006 Nov; 373(1-2):70-6. PubMed ID: 16814762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
    Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
    Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography.
    Heslop CL; Frohlich JJ; Hill JS
    J Am Coll Cardiol; 2010 Mar; 55(11):1102-9. PubMed ID: 20223364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of plasma myeloperoxidase in ESRD patients.
    Wang AY; Lam CW; Chan IH; Wang M; Lui SF; Sanderson JE
    Am J Kidney Dis; 2010 Nov; 56(5):937-46. PubMed ID: 20638167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction.
    Goldmann BU; Rudolph V; Rudolph TK; Holle AK; Hillebrandt M; Meinertz T; Baldus S
    Free Radic Biol Med; 2009 Jul; 47(1):79-83. PubMed ID: 19362143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease.
    Wainstein RV; Wainstein MV; Ribeiro JP; Dornelles LV; Tozzati P; Ashton-Prolla P; Ewald IP; Vietta G; Polanczyk CA
    Clin Biochem; 2010 Jan; 43(1-2):57-62. PubMed ID: 19651119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock.
    Dominguez-Rodriguez A; Samimi-Fard S; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC
    Am J Cardiol; 2008 Jun; 101(11):1537-40. PubMed ID: 18489929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
    Brodov Y; Behar S; Goldenberg I; Boyko V; Chouraqui P
    Am J Cardiol; 2009 Jul; 104(2):194-8. PubMed ID: 19576345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of serum myeloperoxidase in prediction of mortality in patients with severe heart failure.
    Michowitz Y; Kisil S; Guzner-Gur H; Rubinstein A; Wexler D; Sheps D; Keren G; George J
    Isr Med Assoc J; 2008 Dec; 10(12):884-8. PubMed ID: 19160948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study.
    Ioachimescu AG; Brennan DM; Hoar BM; Hazen SL; Hoogwerf BJ
    Arthritis Rheum; 2008 Feb; 58(2):623-30. PubMed ID: 18240236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.
    Baldus S; Heeschen C; Meinertz T; Zeiher AM; Eiserich JP; Münzel T; Simoons ML; Hamm CW;
    Circulation; 2003 Sep; 108(12):1440-5. PubMed ID: 12952835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of uric acid with mortality in patients with stable coronary artery disease.
    Ndrepepa G; Braun S; King L; Hadamitzky M; Haase HU; Birkmeier KA; Schömig A; Kastrati A
    Metabolism; 2012 Dec; 61(12):1780-6. PubMed ID: 22749121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study.
    Schnabel R; Messow CM; Lubos E; Espinola-Klein C; Rupprecht HJ; Bickel C; Sinning C; Tzikas S; Keller T; Genth-Zotz S; Lackner KJ; Münzel TF; Blankenberg S
    Eur Heart J; 2008 Mar; 29(5):649-57. PubMed ID: 18263867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive prognostic value of NT-proBNP over TIMI risk score in intermediate-risk patients with acute coronary syndrome.
    Eren NK; Ertaş F; Yüksek U; Cakir C; Nazli C; Köseoğlu M; Ergene O
    Turk Kardiyol Dern Ars; 2009 Jan; 37(1):1-8. PubMed ID: 19225247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease.
    Papa A; Emdin M; Passino C; Michelassi C; Battaglia D; Cocci F
    Clin Chim Acta; 2008 Sep; 395(1-2):27-31. PubMed ID: 18498767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.